Journal
CELL METABOLISM
Volume 19, Issue 1, Pages 155-161Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2013.11.014
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research [CIHR-MOP-82701]
- CIHR Doctoral Vanier Canada scholarship
- Canadian Diabetes Association postdoctoral fellowship
- Toronto General Research Institute postdoctoral fellowship
- Banting and Best Diabetes Centre graduate studentship
Ask authors/readers for more resources
The fat-derived hormone leptin binds to its hypothalamic receptors to regulate glucose homeostasis. Leptin is also synthesized in the stomach and subsequently binds to its receptors expressed in the intestine, although the functional relevance of such activation remains largely unknown. We report here that intrajejunal leptin administration activates jejunal leptin receptors and signals through a phosphatidylinositol 3-kinase (PI3K)-dependent and signal transducer and activator of transcription 3 (STAT3)-independent signaling pathway to lower glucose production in healthy rodents. Jejunal leptin action is sufficient to lower glucose production in uncontrolled diabetic and high-fat-fed rodents and contributes to the early antidiabetic effect of duodenal-jejunal bypass surgery. These data unveil a glucoregulatory site of leptin action and suggest that enhancing leptin-PI3K signaling in the jejunum lowers plasma glucose concentrations in diabetes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available